Expand Content

Alex Golden, MD


Alex Golden, MD
Department: Pediatric Cardiology
Location: Cleveland Clinic Main Campus
Mail Code M41
9500 Euclid Avenue
Cleveland, OH 44195
Alex Golden, MD
Department: Pediatric Cardiology
Location: Hillcrest Hospital
Mail Code M41
6770 Mayfield Road
Mayfield Heights, OH 44124
Type of Doctor:
Children & Adolescents Only

Biographical Sketch

Dr. Golden completed his pediatric cardiology training at the Children’s Hospital of Philadelphia in 2005 and went on to a fellowship in interventional cardiology at New York Presbyterian Hospital/Columbia. He previously served as Director of the Pediatric Cardiac Catheterization Program at Rainbow Babies and Children’s Hospital. He joined the Cleveland Clinic Children’s Hospital in 2009 as an interventional pediatric cardiologist. He is very active in lecturing to and educating trainees, including students, residents and fellows.  He is energetic in his research endeavors and in developing continuous improvement measures to enhance quality, safety, patient satisfaction, and employee satisfaction at the Cleveland Clinic.

Education & Fellowships

Fellowship - Columbia Presbyterian Medical Center
Interventional Pediatric Cardiology
New York, NY
Fellowship - Children's Hospital of Philadelphia
Pediatric Cardiology
Philadelphia, PA USA
Residency - Columbia Presbyterian Medical Center
New York, NY
Medical School - Mount Sinai School of Medicine
New York, NY USA
Undergraduate - Amherst College
Amherst, MA USA


  • Pediatrics- Pediatric Cardiology

Specialty Interests

Pediatric cardiology, including acquired heart disease in children and congenital heart disease in children and adults, medical treatment of infantile hemangiomas Diagnostic and interventional cardiac catheterization, congenital heart disease, medical treatment of hemangiomas

Awards & Honors

U.S. News and World Report/Castle Connolly Top Doctor


American Academy of Pediatrics
American College of Cardiology

Treatment & Services

  • Department of Pediatric Cardiology & CT Surgery
  • Medical Treatment of Hemangiomas
  • Pediatric Cardiology

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 11/19/2014, Dr. Golden has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English